EMJ Podcast: Insights For Healthcare Professionals

Cherry Lim joins the EMJ Podcast for a rapid-fire discussion on data, modelling, and antimicrobial resistance. From surveillance gaps to the role of AI, she shares insights into how data is shaping the future of AMR research and policy.

Monga reflects on global urology practice, prevention challenges, and equity in care delivery. This episode explores how stone management adapts across healthcare systems and what needs to change to improve outcomes worldwide.

Timestamps: 00:00 – Global experience 02:20 – Resource adaptation 05:00 – Public health challenges 07:40 – Equity in urology 10:30 – Future advice

From device development to real-world surgical impact, Manoj Monga discusses how innovation is transforming stone management. This episode covers emerging technologies, procedural advances, and the future of minimally invasive care.

Timestamps: 00:00 – Innovation pipeline 02:40 – Device development 05:30 – Surgical advances 08:10 – Technology trends 10:50 – Improving outcomes

In this episode of Onc Now, Patricia Ganz sits down with EMJ to explore the evolving field of cancer survivorship. From managing long-term treatment effects to improving transitions into post-treatment care, she highlights key gaps in research, the growing role of patient-reported outcomes, and the importance of integrating policy, advocacy, and clinical practice to better support survivors.

Timestamps:

00:00 – Introduction

01:24 - Career survivorship inspiration

03:10 - Survivorship field evolution

04:10 - Late effects challenges

06:40 - Post-treatment care transition

07:58 - Patient-reported outcomes impact

10:14 - Advocacy policy research intersection

13:29 - Advice for new researchers

15:07 – Bench to beside challenges

17:40 – Equipping younger clinicians

19:16 - Future survivorship innovations

20:14 - Three survivorship wishes

The following podcasts were funded by Edgewise Therapeutics.

Disclaimers: The views and opinions expressed in these podcasts are those of the individual speakers and do not necessarily reflect those of Edgewise Therapeutics or EMJ.

The speakers received honoraria for participating in this recording.

Becker muscular dystrophy (Becker) affects more than just motor function. This episode features Elias Bracamonte, an individual living with Becker, and Gloria Bracamonte, his wife and a Becker patient advocate. Through sharing their story, they dive into the quality of life impacts of Becker on patients and their loved ones.

Manoj Monga explores the evolving understanding of kidney stone pathophysiology, from metabolic drivers to recurrence risk. This episode unpacks how clinicians balance acute intervention with long-term prevention strategies.

Timestamps:

00:00 – Monga's background 02:30 – Pathophysiology explained 05:10 – Recurrence risk factors 08:20 – Dietary management 11:00 – Prevention versus surgery

In this rapid-fire episode, Manoj Monga tackles common myths about kidney stones, shares clinical preferences, and highlights key innovations shaping modern endourology. A concise, high-yield overview of the field.

In the final episode, Debbie Palmer discusses the real-world challenges of implementing allergy prevention strategies. From clinician awareness and public messaging to managing parental anxiety, this episode highlights how evidence can successfully translate into practice.

Timestamps:

00:49 – Barriers and awareness

02:09 – Research shaping practice

03:54 – Parental anxiety

06:15 – UPS food

07:53 – Key takeaways

What is the science behind early allergen introduction? In Part 2, Debbie Palmer explains the immunological basis of oral tolerance, addresses persistent myths, and outlines best practices for introducing allergens, especially in high-risk infants.

Timestamps:

00:56 – Allergen introduction

02:03 – Non-breastfeeding approaches

02:54 – Biggest myth

03:49 – Tolerance versus sensitisation

04:48 – High-risk patients

05:25 – Weaning diet

06:49 – Prohibited foods

In this episode of Hema Now, Karina Yazdanbakhsh speaks about her journey into immunology, the challenges of alloimmunisation, and the evolving landscape of transfusion medicine. She also reflects on receiving the prestigious Henry M. Stratton Medal for Basic Research at ASH 2025 and what this recognition means for her work. The conversation explores key insights from ASH 2025, highlights pressing immunological issues in sickle cell disease, and looks ahead to emerging technologies shaping personalised transfusion strategies.

Timestamps:

00:00 – Introduction

00:59 - Stratton Medal meaning

02:19 - ASH 2025 highlights

13:11 - Sickle cell challenges

17:00 - Immune tolerance evolution

18:55 - Institute research priorities

27:20 - Novel therapeutics role

29:04 - Early career advice

29:43 - Emerging technologies impact

32:30 – Three magic wishes for healthcare